These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11460407)

  • 1. [CSE inhibitors after coronary event. How soon administered?].
    MMW Fortschr Med; 2001 May; 143(22):52. PubMed ID: 11460407
    [No Abstract]   [Full Text] [Related]  

  • 2. Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial.
    Den Hartog FR; Van Kalmthout PM; Van Loenhout TT; Schaafsma HJ; Rila H; Verheugt FW
    Int J Clin Pract; 2001 Jun; 55(5):300-4. PubMed ID: 11452676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pravastatin therapy and the risk of stroke.
    Meilof JF; Uitdehaag BM
    N Engl J Med; 2000 Dec; 343(25):1895; author reply 1895-6. PubMed ID: 11117989
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute coronary syndrome. Early lipid reduction decreases risk of recurrence].
    MMW Fortschr Med; 2001 Apr; 143(16):60. PubMed ID: 11368001
    [No Abstract]   [Full Text] [Related]  

  • 5. Pravastatin therapy and the risk of stroke.
    Fruchter O
    N Engl J Med; 2000 Dec; 343(25):1895; author reply 1895-6. PubMed ID: 11117990
    [No Abstract]   [Full Text] [Related]  

  • 6. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; McCabe CH; Cairns R; Tonkin AM; Sacks FM; Jackson G; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1405-10. PubMed ID: 16226162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial.
    Thompson PL; Meredith I; Amerena J; Campbell TJ; Sloman JG; Harris PJ;
    Am Heart J; 2004 Jul; 148(1):e2. PubMed ID: 15215811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study].
    Uguccioni M
    Ital Heart J Suppl; 2001 Mar; 2(3):316-7. PubMed ID: 11307791
    [No Abstract]   [Full Text] [Related]  

  • 9. [Care Study. Secondary prevention after myocardial infarct in moderately elevated total cholesterol].
    Bönner G
    Fortschr Med; 1997 Jun; 115(17):57-8. PubMed ID: 9312546
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
    Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can early treatment with atorvastatin (Lipitor) improve the outcome of patients with acute coronary syndromes?
    Johnson K; Breen WJ
    J Fam Pract; 2001 Jul; 50(7):572. PubMed ID: 11485701
    [No Abstract]   [Full Text] [Related]  

  • 12. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
    MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive lipid-lowering regimen halts CHD progression.
    Geriatrics; 2004 Jan; 59(1):44. PubMed ID: 14755869
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
    Antman EM
    Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a 'treatment gap' in acute coronary syndromes?
    Krause BR; Newton RS
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1046-7. PubMed ID: 14582446
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
    MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of the early administration of pravastatin on C-reactive protein and interleukin-6 levels in the acute phase of myocardial infarction with ST segment elevation].
    Gonzálvez M; Ruiz Ros JA; Pérez-Paredes M; Lozano ML; Giménez DM; Martínez-Corbalán F; Carnero A; Cubero T; Gómez AE; Vicente V
    Rev Esp Cardiol; 2004 Oct; 57(10):916-23. PubMed ID: 15469788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute coronary syndromes: new developments in pharmacological treatment strategies.
    Gylys K; Gold M
    Crit Care Nurse; 2000 Apr; Suppl():3-14; quiz 15-6. PubMed ID: 11876169
    [No Abstract]   [Full Text] [Related]  

  • 20. [In acute coronary syndrome. Seize platelets with pliers].
    MMW Fortschr Med; 2002 Nov; 144(45):61. PubMed ID: 12534069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.